2014
DOI: 10.3329/bjp.v9i4.19989
|View full text |Cite
|
Sign up to set email alerts
|

Tubeimoside-1 upregulates p21 expression and induces apoptosis and G2/M phase cell cycle arrest in human bladder cancer T24 cells

Abstract: Tubeimoside-1 (TBMS1) is a triterpenoid saponin with potent anticancer properties. In this study, for the first, we examined the anti-proliferative effects of TBMS1 in human bladder cancer T24 cells and its ability to induce apoptosis and cell cycle arrest. Our results demonstrated that TBMS1 decreased the cell viability of bladder cancer T24 cells in a dose-dependent manner. Flow cytometric analysis showed that TBMS1 significantly triggered apoptosis in T24 cells and arrested cell cycle at G2/M phase in a dos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 43 publications
(51 reference statements)
0
2
0
Order By: Relevance
“…JEG-3, T24, and A375 cells displayed significant G2/M phase arrest followed by the treatment Tubeimoside-1 as a potential natural cancer killer Natural Product Communications Vol. 13 (5) 2018 645 of tubeimoside-1 [40][41][42]. An investigation on anti-cancer activity against SKOV-3 cells has proved that pro-apoptotic property of tubeimoside-1 was accredited to G2/M phase arrest [43].…”
Section: Tubeimoside-1 and Cell Cycle Arrestmentioning
confidence: 99%
“…JEG-3, T24, and A375 cells displayed significant G2/M phase arrest followed by the treatment Tubeimoside-1 as a potential natural cancer killer Natural Product Communications Vol. 13 (5) 2018 645 of tubeimoside-1 [40][41][42]. An investigation on anti-cancer activity against SKOV-3 cells has proved that pro-apoptotic property of tubeimoside-1 was accredited to G2/M phase arrest [43].…”
Section: Tubeimoside-1 and Cell Cycle Arrestmentioning
confidence: 99%
“…Annexin V-FITC assay (annexin V-FITC apoptosis detection kit) was used to quantify the extent of apoptosis induced by naringenin chalcone in U87MG human glioblastoma cells (Rasul et al, 2014). In brief, U87MG cells at a density of 2 x 10 5 cells/mL were seeded and then subjected to the treatment of naringenin chalcone at increasing doses (0, 10, 75 and 100 µM).…”
Section: Apoptosis Quantification Using Annexin V-fitc Flow Cytometrimentioning
confidence: 99%